Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
1 - 50 out of 68Page size: 50
  1. 2022
  2. Published

    Endotrophin as a Marker of Complications in a Type 2 Diabetes Cohort

    Tougaard, N. H., Møller, A. L., Rønn, P. F., Hansen, T. W., Genovese, F., Karsdal, M. A., Rasmussen, D. G. K. & Rossing, Peter, Nov 2022, In: Diabetes Care. 45, 11, p. 2746-2748 3 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trials

    Zobel, E. H., von Scholten, B. J., Hansen, T. W., Persson, F., Rasmussen, S., Wolthers, B. & Rossing, Peter, Feb 2022, In: Diabetes, Obesity and Metabolism. 24, 2, p. 281-288 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    16-LB: Effects of Finerenone in Patients with CKD and T2D Are Independent of HbA1c at Baseline, HbA1c Variability, and Duration of Diabetes

    Mcgill, J. B., Agarwal, R., Anker, S., Bakris, G., Filippatos, G., Pitt, B., Ruilope, L. M., Birkenfeld, A. L., Caramori, L., Brinker, M. D., Joseph, A., Lage, A. Z., Lawatscheck, R., Scott, C. & Rossing, Peter, 2022, In: Diabetes. 71, Supplement_1, 16-LB.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  5. Published

    A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

    Heerspink, H. J. L. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2022, In: Kidney International. 101, 1, p. 174-184 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor

    Rotbain Curovic, V., Houlind, Morten Baltzer, Hansen, T. W., Eugen-Olsen, J., Laursen, J. C., Eickhoff, M. K., Persson, F. & Rossing, Peter, 2022, In: Frontiers in Pharmacology. 13, 799915.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Association between plasma apolipoprotein M and cardiac autonomic neuropathy in type 1 diabetes

    Safi, M., Borup, A., Stevns Hansen, C., Rossing, Peter, Thorsten Jensen, M. & Christoffersen, Christina, 2022, In: Diabetes Research and Clinical Practice. 189, 7 p., 109943.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Pooled Secondary Analysis

    Pitt, B., Agarwal, R., Anker, S. D., Ruilope, L. M., Rossing, Peter, Ahlers, C., Brinker, M., Joseph, A., Lambelet, M., Lawatscheck, R. & Filippatos, G. S., 2022, In: JAMA network open. 5, 10, 10 p., E2236123.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Baseline risk markers and visit-to-visit variability in relation to kidney outcomes - A post-hoc analysis of the PERL study

    Curovic, V. R., Roy, N., Hansen, T. W., Caramori, M. L., Cherney, D. Z., Boer, I. H. D., Emanuele, M. A., Hirsch, I. B., Lingvay, I., Mcgill, J. B., Polsky, S., Pop-Busui, R., Sigal, R. J., Tuttle, K. R., Umpierrez, G. E., Wallia, A., Rosas, S. E. & Rossing, Peter, 2022, In: Diabetes Research and Clinical Practice. 193, 8 p., 110119.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes

    Ruilope, L. M., Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Rossing, Peter, Sarafidis, P., Schmieder, R. E., Joseph, A., Rethemeier, N., Nowack, C., Bakris, G. L. & the FIDELIO-DKD Investigators, T. F. I., 2022, In: Hypertension. 79, 12, p. 2685-2695 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Is Associated With Disturbances in TCA, Lipid, and Glucose Metabolism

    Hansen, C. S., Suvitaival, T., Theilade, Karen Simone, Mattila, I., Lajer, M., Trošt, K., Ahonen, L., Hansen, T. W., Legido-Quigley, C., Rossing, Peter & Ahluwalia, Tarun Veer Singh, 2022, In: Frontiers in Endocrinology. 13, 831793.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: The FIDELITY pooled analysis

    Agarwal, R., Filippatos, G., Pitt, B., Anker, S. D., Rossing, Peter, Joseph, A., Kolkhof, P., Nowack, C., Gebel, M., Ruilope, L. M. & Bakris, G. L., 2022, In: European Heart Journal. 43, 6, p. 474-484 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes

    Ferreira-Divino, L. F., Suvitaival, T., Curovic, V. R., Tofte, N., Trošt, K., Mattila, I. M., Theilade, Karen Simone, Winther, S. A., Hansen, T. W., Frimodt-Møller, M., Legido-Quigley, C. & Rossing, Peter, 2022, In: Cardiovascular Diabetology. 21, 10 p., 135.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    Clinical perspective—evolving evidence of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes

    Rossing, Peter, 2022, In: Kidney International Supplements. 12, 1, p. 27-35 9 p.

    Research output: Contribution to journal › Review › Research › peer-review

  15. Published

    Copeptin and renal function decline, cardiovascular events and mortality in type 1 diabetes

    Heinrich, N. S., Theilade, S., Winther, S. A., Tofte, N., Ahluwalia, Tarun Veer Singh, Jeppesen, J. L., Persson, F., Hansen, T. W., Goetze, Jens P. & Rossing, Peter, 2022, In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 37, 1, p. 100–107

    Research output: Contribution to journal › Journal article › Research › peer-review

  16. Published

    Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKD

    the DAPA-CKD Trial Committees and Investigators, T. D. T. C. A. I., 2022, In: Journal of the American Society of Nephrology. 33, 11, p. 2094-2107 14 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  17. Published

    Dapagliflozin Improves the Urinary Proteomic Kidney-Risk Classifier CKD273 in Type 2 Diabetes with Albuminuria: A Randomized Clinical Trial

    Curovic, V. R., Eickhoff, M. K., Rönkkä, T., Frimodt-Møller, M., Hansen, T. W., Mischak, H., Rossing, Peter, Ahluwalia, Tarun Veer Singh & Persson, F., 2022, In: Diabetes Care. 45, 11, p. 2662-2668 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  18. Published

    Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials

    Rossing, P., Inzucchi, S. E., Vart, P., Jongs, N., Docherty, K. F., Jhund, P. S., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Solomon, S. D., DeMets, D. L., Bengtsson, O., Lindberg, M., Langkilde, A. M., Sjöstrand, M., Stefansson, B. V., Karlsson, C., Chertow, G. M. & 7 others, Hou, F. F., Correa-Rotter, R., Toto, R. D., Wheeler, D. C., McMurray, J. J. V., Heerspink, H. J. L. & DAPA-CKD and DAPA-HF Trial Committees and Investigators, D. A. D. T. C. A. I., 2022, In: The Lancet Diabetes and Endocrinology. 10, 1, p. 24-34 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. Published

    Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)

    de Boer, I. H., Khunti, K., Sadusky, T., Tuttle, K. R., Neumiller, J. J., Rhee, C. M., Rosas, S. E., Rossing, Peter & Bakris, G., 2022, In: Diabetes Care. 45, 12, p. 3075-3090

    Research output: Contribution to journal › Journal article › Research › peer-review

  20. Published

    Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)

    de Boer, I. H., Khunti, K., Sadusky, T., Tuttle, K. R., Neumiller, J. J., Rhee, C. M., Rosas, S. E., Rossing, Peter & Bakris, G., 2022, In: Kidney International. 102, 5, p. 974-989 16 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  21. Published

    Diagnostic and prognostic value of the electrocardiogram in stable outpatients with type 2 diabetes

    Gregers, M. C. T., Schou, Morten, Jensen, M. T., Jensen, J., Petrie, M. C., Vilsbøll, Tina, Goetze, Jens P. , Rossing, Peter & Jørgensen, P. G., 2022, In: Scandinavian Cardiovascular Journal. 56, 1, p. 256-263 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  22. Published

    Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals

    Winkler, T. W., Rasheed, H., Teumer, A., Gorski, M., Rowan, B. X., Stanzick, K. J., Thomas, L. F., Tin, A., Hoppmann, A., Chu, A. Y., Tayo, B., Thio, C. H. L., Cusi, D., Chai, J-F., Sieber, K. B., Horn, K., Li, M., Scholz, M., Cocca, M., Wuttke, M. & 31 others, van der Most, P. J., Yang, Q., Ghasemi, S., Nutile, T., Li, Y., Pontali, G., Günther, F., Dehghan, A., Correa, A., Parsa, A., Feresin, A., de Vries, A. P. J., Zonderman, A. B., Smith, A. V., Oldehinkel, A. J., De Grandi, A., Rosenkranz, A. R., Franke, A., Teren, A., Metspalu, A., Hicks, A. A., Morris, A. P., Tönjes, A., Morgan, A., Podgornaia, A. I., Christensen, K., Lind, L., Kovacs, P., Rossing, Peter, Loos, Ruth & LifeLines Cohort Study, L. C. S., 2022, In: Communications Biology . 5, p. 580 20 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  23. Published

    Distal symmetrical polyneuropathy is present in all individuals with diabetes and foot ulcers - and does not associate with healing time

    Mizrak, H. I., Hansen, T. W., Andersen, Jonas Askø, Rossing, Peter, Rasmussen, A. & Hansen, C. S., 2022, In: Journal of Diabetes and its Complications. 36, 12, 108353.

    Research output: Contribution to journal › Journal article › Research › peer-review

  24. Published

    Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial

    Waijer, S. W., Vart, P., Cherney, D. Z. I., Chertow, G. M., Jongs, N., Langkilde, A. M., Mann, J. F. E., Mosenzon, O., McMurray, J. J. V., Rossing, Peter, Correa-Rotter, R., Stefansson, B. V., Toto, R. D., Wheeler, D. C. & Heerspink, H. J. L., 2022, In: Diabetologia. 65, 7, p. 1085-1097 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  25. Published

    Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trial

    Ersbøll, M., Jürgens, M., Hasbak, P., Kjær, Andreas, Wolsk, E., Zerahn, B., Brandt-Jacobsen, N. H., Gæde, P., Rossing, Peter, Faber, Jens, Inzucchi, S. E., Gustafsson, Finn, Schou, Morten & Kistorp, Caroline Michaela Nervil, 2022, In: International Journal of Cardiovascular Imaging. 38, p. 579–587

    Research output: Contribution to journal › Journal article › Research › peer-review

  26. Published

    Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER

    Shaman, A. M., Bain, S. C., Bakris, G. L., Buse, J. B., Idorn, T., Mahaffey, K. W., Mann, J. F. E., Nauck, M. A., Rasmussen, S., Rossing, Peter, Wolthers, B., Zinman, B. & Perkovic, V., 2022, In: Circulation. 145, 8, p. 575-585 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  27. Published

    Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

    Tougaard, N. H., Frimodt-Møller, M., Salmenkari, H., Stougaard, E. B., Zawadzki, A. D., Mattila, I. M., Hansen, T. W., Legido-Quigley, C., Hörkkö, S., Forsblom, C., Groop, P. H., Lehto, M. & Rossing, Peter, 2022, In: Journal of Clinical Medicine. 11, 13, 3573.

    Research output: Contribution to journal › Journal article › Research › peer-review

  28. Published

    Effects of Dapagliflozin in People without Diabetes and with Microalbuminuria

    Heerspink, H. J. L., Chertow, G. M., Jongs, N., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Langkilde, A. M. & Wheeler, D. C., 2022, In: Clinical Journal of the American Society of Nephrology. 17, 11, p. 1665-1668 4 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  29. Published

    Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results

    Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Rossing, Peter, Ruilope, L. M., Boletis, J., Toto, R., Umpierrez, G. E., Wanner, C., Wada, T., Scott, C., Joseph, A., Ogbaa, I., Roberts, L., Scheerer, M. F., Bakris, G. L. & FIDELIO-DKD Investigators, F. I., 2022, In: Nephrology Dialysis Transplantation. p. 1261–1269 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  30. Published

    Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic Regions

    Vart, P., Correa-Rotter, R., Hou, F. F., Jongs, N., Chertow, G. M., Langkilde, A. M., McMurray, J. J. V., Rossing, Peter, Sjöström, C. D., Stefansson, B. V., Toto, R. D., Douthat, W., Escudero, E., Isidto, R., Khullar, D., Bajaj, H. S., Wheeler, D. C. & Heerspink, H. J. L., 2022, In: Kidney International Reports. 7, 4, p. 699-707 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  31. Published

    Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP-1RA treatment: A subgroup analysis from the FIDELIO-DKD trial

    Rossing, Peter, Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Amod, A., Marre, M., Joseph, A., Lage, A., Scott, C., Bakris, G. L. & the FIDELIO-DKD Investigators, T. F. I., 2022, In: Diabetes, Obesity and Metabolism. 24, 1, p. 125-134 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  32. Published

    Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence

    Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., Sadusky, T., Tandon, N., Tuttle, K. R., Wanner, C., Wilkens, K. G., Zoungas, S., Craig, J. C., Tunnicliffe, D. J., Tonelli, M. A., Cheung, M. & 2 others, Earley, A. & de Boer, I. H., 2022, In: Kidney International. 102, 5, p. 990-999 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  33. Published

    Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial

    FIGARO DKD Investigators, F. D. I., 2022, In: Circulation. 145, 6, p. 437-447 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  34. Published

    Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes

    Filippatos, G., Anker, S. D., Pitt, B., Rossing, Peter, Joseph, A., Kolkhof, P., Lambelet, M., Lawatscheck, R., Bakris, G. L., Ruilope, L. M. & Agarwal, R., 2022, In: JACC: Heart Failure. 10, 11, p. 860-870 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  35. Published

    Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

    Rossing, Peter, Burgess, E., Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Gillard, P., Macisaac, R. J., Wainstein, J., Joseph, A., Brinker, M., Roessig, L., Scott, C., Bakris, G. L. & FIDELIO-DKD Investigators, F. I., 2022, In: Diabetes Care. 45, 4, p. 888-897 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  36. Published

    Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

    Rossing, Peter, Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Birkenfeld, A. L., McGill, J. B., Rosas, S. E., Joseph, A., Gebel, M., Roberts, L., Scheerer, M. F., Bakris, G. L. & Agarwal, R., 2022, In: Diabetes Care. 45, 12, p. 2991-2998 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  37. Published

    Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy

    FIDELIO-DKD Investigators, F. I., 2022, In: Kidney International Reports. 7, 1, p. 36-45

    Research output: Contribution to journal › Journal article › Research › peer-review

  38. Published

    Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO-DKD trial

    Filippatos, G., Pitt, B., Agarwal, R., Farmakis, D., Ruilope, L. M., Rossing, Peter, Bauersachs, J., Mentz, R. J., Kolkhof, P., Scott, C., Joseph, A., Bakris, G. L., Anker, S. D. & FIDELIO-DKD Investigators, F. I., 2022, In: European Journal of Heart Failure. 24, 6, p. 996-1005 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  39. Published

    Flexor Tendon Tenotomy Treatment of the Diabetic Foot: A Multicenter Randomized Controlled Trial

    Andersen, Jonas Askø, Rasmussen, A., Engberg, S., Bencke, J., Frimodt-Møller, M., Kirketerp-Møller, K. & Rossing, Peter, 2022, In: Diabetes Care. 45, 11, p. 2492-2500 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  40. Published

    Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies

    Gorski, M., Rasheed, H., Teumer, A., Thomas, L. F., Graham, S. E., Sveinbjornsson, G., Winkler, T. W., Günther, F., Stark, K. J., Chai, J-F., Tayo, B. O., Wuttke, M., Li, Y., Tin, A., Ahluwalia, T. S., Ärnlöv, J., Åsvold, B. O., Bakker, S. J. L., Banas, B., Bansal, N. & 29 others, Biggs, M. L., Biino, G., Böhnke, M., Boerwinkle, E., Bottinger, E. P., Brenner, H., Brumpton, B., Carroll, R. J., Chaker, L., Chalmers, J., Chee, M., Chee, M., Cheng, C., Chu, A. Y., Ciullo, M., Cocca, M., Cook, J. P., Coresh, J., Cusi, D., de Borst, M. H., Degenhardt, F., Eckardt, K., Endlich, K., Evans, M. K., Feitosa, M. F., Franke, A., Freitag-Wolf, S., Rossing, Peter & LifeLines Cohort Study, L. C. S., 2022, In: Kidney International. 102, 3, p. 624-639 16 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  41. Published

    Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial

    FIDELIO-DKD Investigators, F. I., 2022, In: Journal of the American Society of Nephrology. 33, 1, p. 225-237 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  42. Published

    Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology

    Waijer, S. W., Provenzano, M., Mulder, S., Rossing, Peter, Persson, F., Perkovic, V. & Heerspink, H. J. L., 2022, In: Diabetes, Obesity and Metabolism. 24, 6, p. 983-990 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  43. Published

    Increased mitochondrial proton leak and glycolysis in peripheral blood mononuclear cells in type-1-diabetes

    Lopes de Melo, J. M., Laursen, J. C., Søndergaard-Heinrich, N., Bull Rasmussen, I. K., Hansen, C. S., Frimodt-Møller, M., Rossing, Peter & Størling, Joachim, 2022, In: Heliyon. 8, 12, 7 p., e12304.

    Research output: Contribution to journal › Journal article › Research › peer-review

  44. Published

    Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone

    Agarwal, R., Anker, S. D., Bakris, G., Filippatos, G., Pitt, B., Rossing, Peter, Ruilope, L., Gebel, M., Kolkhof, P., Nowack, C., Joseph, A. & FIDELIO-DKD and FIGARO-DKD Investigators, F. A. F. I., 2022, In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 37, 6, p. 1014–1023

    Research output: Contribution to journal › Journal article › Research › peer-review

  45. Published

    KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease

    de Boer, I. H., Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., Sadusky, T., Tandon, N., Tuttle, K. R., Wanner, C., Wilkens, K. G., Zoungas, S., Jadoul, M., Winkelmayer, W. C., Tonelli, M. A. & 7 others, Craig, J. C., Strippoli, G. F. M., Tunnicliffe, D. J., Higgins, G. Y., Natale, P., Cooper, T. E. & Willis, N. S., 2022, In: Kidney International. 102, 5, p. S1-S127 127 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  46. Published

    Kidney oxygenation, perfusion and blood flow in people with and without type 1 diabetes

    Laursen, J. C., Søndergaard-Heinrich, N., Haddock, B., Rasmussen, I. K. B., Hansen, C. S., Larsson, Henrik Bo Wiberg, Groop, P., Bjornstad, P., Frimodt-Møller, M., Andersen, U. B. & Rossing, Peter, 2022, In: Clinical Kidney Journal. 15, 11, p. 2072-2080 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  47. Published

    Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes: A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial

    Wretlind, A., Zobel, E. H., De Zawadzki, A., Ripa, Rasmus Sejersten, Curovic, V. R., Von Scholten, B. J., Mattila, I. M., Hansen, T. W., Kjær, Andreas, Vestergaard, H., Rossing, Peter & Legido-Quigley, C., 2022, In: Frontiers in Clinical Diabetes and Healthcare. 3, 8 p., 856485.

    Research output: Contribution to journal › Journal article › Research › peer-review

  48. Published

    Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuria

    McGill, J. B., Haller, H., Roy-Chaudhury, P., Cherrington, A., Wada, T., Wanner, C., Ji, L. & Rossing, Peter, 2022, In: BMJ open diabetes research & care. 10, 4

    Research output: Contribution to journal › Review › Research › peer-review

  49. Published

    Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., Rossing, Peter, Tankova, T., Tsapas, A. & Buse, J. B., 2022, In: Diabetes Care. 45, 11, p. 2753-2786 34 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  50. Published

    Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., Rossing, Peter, Tankova, T., Tsapas, A. & Buse, J. B., 2022, In: Diabetologia. 65, 12, p. 1925-1966 42 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  51. Published

    Microalbuminuria Constitutes a Clinical Action Item for Clinicians in 2021

    Rossing, Peter & Epstein, M., 2022, In: American Journal of Medicine. 135, 5, p. 576-580 5 p.

    Research output: Contribution to journal › Review › Research › peer-review

Previous 1 2 Next

ID: 12937790